LRMR Stock Price
LRMR
$2.36
+$0.04(+1.72%)
42
Overall
60
Value
54
Tech
13
Quality
Market Cap
$286.72M
Volume
146.71K
52W Range
-- - --
Target Price
$14.40
LRMR stock price is $2.36 (+1.72% on the day), giving LRMR a market cap of $286.72M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
LRMR Stock Overview
- Price
- $2.36
- Previous close
- $2.32
- Open
- $2.35
- Market cap
- $286.72M
- 1-year price target
- $14.40
- MarketXLS Rank
- 42
About LRMR
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LRMR | $2.36 | +1.7% | 146.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |